I-Mab (IMAB) News Today → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free IMAB Stock Alerts $1.75 -0.02 (-1.13%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 30, 2024 | prnewswire.comI-MAB Filed 2023 Annual Report on Form 20-FApril 16, 2024 | msn.comOmega Therapeutics CFO Joshua Reed to departApril 16, 2024 | marketbeat.comI-Mab (NASDAQ:IMAB) Short Interest UpdateI-Mab (NASDAQ:IMAB - Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 1,170,000 shares, an increase of 7.3% from the March 15th total of 1,090,000 shares. Based on an average daily volume of 436,300 shares, the days-to-cover ratio is presently 2.7 days.April 12, 2024 | markets.businessinsider.comI-MAB Buy Rating Justified by Strong Leadership and Promising PipelineApril 12, 2024 | marketbeat.comNeedham & Company LLC Reaffirms Buy Rating for I-Mab (NASDAQ:IMAB)Needham & Company LLC restated a "buy" rating and set a $6.00 target price on shares of I-Mab in a research report on Friday.April 5, 2024 | prnewswire.comI-Mab to Participate at the 23rd Annual Needham Virtual Healthcare ConferenceApril 4, 2024 | investing.comI-Mab completes divestiture of its Shanghai unit for $80 millionApril 2, 2024 | uk.finance.yahoo.comI-Mab Announces Closing of the Divestiture of Business Operations in ChinaApril 2, 2024 | prnewswire.comI-Mab Announces Closing of the Divestiture of Business Operations in ChinaMarch 20, 2024 | marketbeat.comI-Mab Expected to Post FY2025 Earnings of ($1.75) Per Share (NASDAQ:IMAB)I-Mab (NASDAQ:IMAB - Free Report) - HC Wainwright raised their FY2025 earnings per share (EPS) estimates for shares of I-Mab in a research note issued on Monday, March 18th. HC Wainwright analyst A. Fein now anticipates that the company will post earnings of ($1.75) per share for the year, up froMarch 18, 2024 | marketbeat.comHC Wainwright Reaffirms Buy Rating for I-Mab (NASDAQ:IMAB)HC Wainwright reissued a "buy" rating and issued a $8.00 price objective (down from $18.00) on shares of I-Mab in a research note on Monday.March 18, 2024 | finance.yahoo.comI-Mab Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsMarch 14, 2024 | finance.yahoo.comI-Mab Reports Full Year 2023 Financial Results and Business UpdateFebruary 22, 2024 | benzinga.comI-MAB Stock (NASDAQ:IMAB), Short Interest ReportFebruary 18, 2024 | seekingalpha.comI-Mab: Trading Below Net Cash With Multiple Upside OptionsFebruary 7, 2024 | marketwatch.comI-Mab to Divest Chinese Unit for Up to $80MFebruary 7, 2024 | msn.comI-Mab to divest Chinese assets amid rising geopolitical tensionsFebruary 7, 2024 | finance.yahoo.comI-Mab Signs Agreement to Divest its Assets and Business Operations in ChinaJanuary 31, 2024 | marketbeat.comI-Mab (NASDAQ:IMAB) Sees Significant Decline in Short InterestI-Mab (NASDAQ:IMAB - Get Free Report) saw a large decrease in short interest in January. As of January 15th, there was short interest totalling 1,510,000 shares, a decrease of 6.8% from the December 31st total of 1,620,000 shares. Based on an average trading volume of 635,700 shares, the short-interest ratio is currently 2.4 days.January 11, 2024 | msn.comAsian Equities Traded in the US as American Depositary Receipts Advance in Thursday TradingDecember 31, 2023 | uk.finance.yahoo.comI-Mab (IMAB) interactive stock chart – Yahoo FinanceDecember 28, 2023 | benzinga.comI-MAB Stock (NASDAQ:IMAB) Dividends: History, Yield and DatesDecember 21, 2023 | marketbeat.comI-Mab Expected to Earn FY2023 Earnings of ($1.85) Per Share (NASDAQ:IMAB)I-Mab (NASDAQ:IMAB - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2023 earnings per share estimates for shares of I-Mab in a report issued on Monday, December 18th. Cantor Fitzgerald analyst L. Chen anticipates that the company will post earnings per share of ($1.85) for theDecember 21, 2023 | marketbeat.comI-Mab (NASDAQ:IMAB) Given Overweight Rating at Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating on shares of I-Mab in a report on Monday.November 19, 2023 | finance.yahoo.comIndividual investors account for 41% of I-Mab's (NASDAQ:IMAB) ownership, while private equity firms account for 26%November 6, 2023 | finance.yahoo.comI-Mab Announces Participation at Jefferies and Piper Conferences in NovemberNovember 2, 2023 | msn.comI-Mab gains FDA breakthrough tag for kidney disease therapyNovember 2, 2023 | markets.businessinsider.comI-Mab:Felzartamab Granted Breakthrough Therapy Designation By FDA For Primary Membranous NephropathyNovember 2, 2023 | finance.yahoo.comFelzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)November 1, 2023 | finance.yahoo.comI-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023October 16, 2023 | finance.yahoo.comI-Mab Announces Phase 1 Data of Givastomig at ESMO 2023October 10, 2023 | finance.yahoo.comI-Mab and ABL Bio Announce Latest Updates of PD-L1 and 4-1BB Bispecific Antibody TJ-L14B/ABL503October 5, 2023 | insidermonkey.comRay Dalio on Potential US China War and Rise of ChinaSeptember 25, 2023 | markets.businessinsider.comExpert Ratings for I-MABSeptember 25, 2023 | nasdaq.comNeedham Maintains I-Mab - ADR (IMAB) Buy RecommendationSeptember 22, 2023 | finance.yahoo.comUPDATE 1-AbbVie terminates deal with I-Mab to develop cancer drugSeptember 13, 2023 | msn.comI-Mab: Why This Company Trades At A Third The Value Of Its CashSeptember 5, 2023 | markets.businessinsider.comWhere I-MAB Stands With AnalystsSeptember 3, 2023 | uk.finance.yahoo.comI-Mab (IMAB) stock historical prices & data – Yahoo FinanceSeptember 1, 2023 | marketbeat.comShort Interest in I-Mab (NASDAQ:IMAB) Rises By 7.9%I-Mab (NASDAQ:IMAB - Get Free Report) was the recipient of a large increase in short interest in August. As of August 15th, there was short interest totalling 1,640,000 shares, an increase of 7.9% from the July 31st total of 1,520,000 shares. Based on an average daily volume of 344,900 shares, the days-to-cover ratio is currently 4.8 days.August 20, 2023 | marketbeat.comBarclays PLC Boosts Stock Holdings in I-Mab (NASDAQ:IMAB)Barclays PLC increased its position in shares of I-Mab (NASDAQ:IMAB - Free Report) by 30.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 430,406 shares of the company's stock after buying an additional 101,106 shares during tAugust 19, 2023 | msn.comCantor Fitzgerald Reiterates I-Mab - ADR (IMAB) Overweight RecommendationAugust 18, 2023 | markets.businessinsider.comAnalyst Ratings for I-MABAugust 18, 2023 | insidermonkey.comI-Mab (NASDAQ:IMAB) Q2 2023 Earnings Call TranscriptAugust 18, 2023 | marketbeat.comI-Mab (NASDAQ:IMAB) Stock Rating Reaffirmed by Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and issued a $25.00 target price on shares of I-Mab in a research note on Friday.August 17, 2023 | seekingalpha.comI-Mab Biopharma Non-GAAP EPADS of -$1.05 misses by $0.26, revenue of $2.7M misses by $0.3MAugust 17, 2023 | finance.yahoo.comI-Mab Provides Mid-Year 2023 Financial Results, Business and Corporate UpdatesAugust 16, 2023 | seekingalpha.comI-Mab Biopharma 1H 2023 Earnings PreviewAugust 10, 2023 | marketbeat.comI-Mab (IMAB) Scheduled to Post Earnings on ThursdayI-Mab (NASDAQ:IMAB) will be releasing earnings before the market opens on Thursday, August 17, Zacks reports.August 8, 2023 | finance.yahoo.comI-Mab to Report Mid-Year 2023 Financial Results, Business and Corporate Updates on August 17, 2023 Get I-Mab News Delivered to You Automatically Sign up to receive the latest news and ratings for IMAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking: One AI startup's revenue could surge 4,735% (Ad)Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner. Click here to discover the AI chip company IMAB Media Mentions By Week IMAB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMAB News Sentiment▼0.000.42▲Average Medical News Sentiment IMAB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMAB Articles This Week▼01▲IMAB Articles Average Week Get I-Mab News Delivered to You Automatically Sign up to receive the latest news and ratings for IMAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: InterCure News Regulus Therapeutics News CervoMed News Incannex Healthcare News Adicet Bio News Repare Therapeutics News DiaMedica Therapeutics News Prelude Therapeutics News PDS Biotechnology News Sagimet Biosciences News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMAB) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding I-Mab Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
